Showing results (871-880 of 1,559) with videos related to
Sort By:
Pageof 156
Assessment|November 2, 2022
Development and Validation of the Disclosure Expectancy ScaleJoshua D Clapp, Matt J Gray, Brett T Litz, et al.American Journal of Hypertension|March 1, 1993
Calcium antagonists and atherosclerosis. The Multicenter Isradipine/Diuretic Atherosclerosis StudyC D Furberg, N O Borhani, R P Byington, et al.Hypertension (Dallas, Tex. : 1979)|March 1, 1993
Effects of weight reduction on cellular cation metabolism and vascular resistanceD B Jacobs, J R Sowers, A Hmeidan, et al.MMWR. CDC Surveillance Summaries : Morbidity and Mortality Weekly Report. CDC Surveillance Summaries|April 1, 1991
Surveillance of Escherichia coli O157 isolation and confirmation, United States, 1988S M Ostroff, D P Hopkins, R V Tauxe, et al.Current Hypertension Reports|September 2, 2003
Cardiometabolic syndrome: pathophysiology and treatmentJonathan P Castro, Fadi A El-Atat, Samy I McFarlane, et al.Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|April 17, 2023
Spectroscopic characterization of the interactions between poly(2-(trimethylamino)ethyl methacrylate) chloride and the xanthene dyes, 2', 7'-difluorofluorescein and 2, 4, 5, 7-tetraiodofluoresceinLauren J Duvall, Elijah T G Sowers, Cody J Graham, et al.Osteoarthritis and Cartilage|June 13, 2003
Magnetic resonance-detected subchondral bone marrow and cartilage defect characteristics associated with pain and X-ray-defined knee osteoarthritisM F Sowers, C Hayes, D Jamadar, et al.Metabolism: Clinical and Experimental|March 12, 2002
Phosphatidylinositol 3-kinase may mediate isoproterenol-induced vascular relaxation in part through nitric oxide productionEsma Isenović, Mary F Walsh, Ranganath Muniyappa, et al.Acta Endocrinologica|September 1, 1977
The effect of stressful diagnostic studies and surgery on anterior pituitary hormone release in manJ R Sowers, R P Raj, J M Hershman, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|January 24, 2013
Randomized study of antihypertensive efficacy and safety of combination aliskiren/valsartan vs valsartan monotherapy in hypertensive participants with type 2 diabetes mellitusGeorge L Bakris, Suzanne Oparil, Das Purkayastha, et al.Pageof 156